# Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

> **NCT00796224** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 38 (actual)

## Conditions studied

- Acute Otitis Media

## Interventions

- **DRUG:** 60 mg/kg azithromycin ER
- **DRUG:** 30 mg/kg azithromycin IR

## Key facts

- **NCT ID:** NCT00796224
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2010-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796224, "Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00796224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*